Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
Public ClinicalTrials.gov record NCT00036127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00036127
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- aripiprazole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2002
- Primary completion
- Dec 31, 2002
- Completion
- Dec 31, 2002
- Last update posted
- Nov 10, 2013
2002 – 2003
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Anaheim | California | — | — |
| Local Institution | Cerritos | California | — | — |
| Local Institution | Chula Vista | California | — | — |
| Local Institution | Rosemead | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | Atlanta | Georgia | — | — |
| Local Institution | Macon | Georgia | — | — |
| Local Instituton | Hoffman Estates | Illinois | — | — |
| Local Institution | Las Vegas | Nevada | — | — |
| Local Institution | Nashua | New Hampshire | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Beachwood | Ohio | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Charleston | South Carolina | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00036127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2013 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00036127 live on ClinicalTrials.gov.